Neuphoria Therapeutics Inc.

NEUPNasdaq· Pharmaceutical Preparations

Price History

Revenue

$15.6M

Net Income

-$369,632

▲ 97.6% YoY

EPS

$-0.23

▲ 98.8% YoY

Cash

$14.2M

▲ 12.7% YoY

FY 2025 · As of 2025-06-30

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.